Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Researchers ID Antivirals That Can Fight New Infectious Illnesses By: Investor Brand Network May 05, 2023 at 11:10 AM EDT New research has found broad-spectrum antiviral agents that could target RNA virus families that pose substantial threats for future outbreaks. The research was led by Gustavo Garcia Jr. of the Molecular and Medical Pharmacology department at the University of California, Los Angeles. It focused on assessing a group of innate immune agonists that target receptors that recognize pathogens. The coronavirus pandemic has claimed almost 7 million lives around the globe since it started in 2020, which has shed light on the susceptibilities of humans to… Read More>> NOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV About BioMedWire BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge. To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only) For more information, please visit https://www.biomedwire.com Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer BioMedWire (BMW)San Francisco, Californiawww.biomedwire.com415.949.5050 OfficeEditor@BioMedWire.com BioMedWire is part of the InvestorBrandNetwork. Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Researchers ID Antivirals That Can Fight New Infectious Illnesses By: Investor Brand Network May 05, 2023 at 11:10 AM EDT New research has found broad-spectrum antiviral agents that could target RNA virus families that pose substantial threats for future outbreaks. The research was led by Gustavo Garcia Jr. of the Molecular and Medical Pharmacology department at the University of California, Los Angeles. It focused on assessing a group of innate immune agonists that target receptors that recognize pathogens. The coronavirus pandemic has claimed almost 7 million lives around the globe since it started in 2020, which has shed light on the susceptibilities of humans to… Read More>> NOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV About BioMedWire BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge. To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only) For more information, please visit https://www.biomedwire.com Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer BioMedWire (BMW)San Francisco, Californiawww.biomedwire.com415.949.5050 OfficeEditor@BioMedWire.com BioMedWire is part of the InvestorBrandNetwork.
New research has found broad-spectrum antiviral agents that could target RNA virus families that pose substantial threats for future outbreaks. The research was led by Gustavo Garcia Jr. of the Molecular and Medical Pharmacology department at the University of California, Los Angeles. It focused on assessing a group of innate immune agonists that target receptors that recognize pathogens. The coronavirus pandemic has claimed almost 7 million lives around the globe since it started in 2020, which has shed light on the susceptibilities of humans to… Read More>> NOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV About BioMedWire BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge. To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only) For more information, please visit https://www.biomedwire.com Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer BioMedWire (BMW)San Francisco, Californiawww.biomedwire.com415.949.5050 OfficeEditor@BioMedWire.com BioMedWire is part of the InvestorBrandNetwork.